A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells

BACKGROUND: Although cancer of the prostate is one of the most commonly diagnosed cancers in men, no curative treatment currently exists after its progression beyond resectable boundaries. Therefore, new agents for targeted treatment strategies are needed. Cross-linking of tumor antigens with T-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Bühler, P., Wolf, P., Gierschner, D., Schaber, I., Katzenwadel, A., Schultze-Seemann, W., Wetterauer, U., Tacke, M., Swamy, M., Schamel, W. W. A., Elsässer-Beile, U.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755730/
https://www.ncbi.nlm.nih.gov/pubmed/17579857
http://dx.doi.org/10.1007/s00262-007-0348-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755730/
https://www.ncbi.nlm.nih.gov/pubmed/17579857
http://dx.doi.org/10.1007/s00262-007-0348-6

Ejemplares similares